INBX EBITDA Growth
Inhibrx Biosciences Inc · EBITDA Growth
INBX EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported22.33%period ending
INBX TTM EBITDA YoY % (-48.15% → 22.33%)
Year-over-year change
High-resolution chart · PNG
INBX ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 22.3296% | |
| -106.6232% | |
| -107.3604% | |
| -108.6293% | |
| -109.329% | |
| 821.162% | |
| 906.3921% | |
| 1,149.3284% | |
| 1,248.0165% | |
| -71.4362% | |
| -65.2333% | |
| -41.7955% | |
| -44.0117% | |
| -63.4853% | |
| -69.6612% | |
| -52.8529% | |
| -43.3177% | |
| -26.9158% | |
| -13.0094% | |
| -10.1865% | |
| -4.936% | |
| -24.4609% | |
| -67.5672% | |
| -144.3033% | |
| -280.2742% | |
| -147.5676% | |
| -48.1495% |